Market News Archive

Stay updated with the latest announcements

29 Jul 2026

ACI: Board approval for the formation of a new subsidiary company

The company has informed that the Board of Directors of the Company in its meeting held on 28 July 2026 approved the formation of a new subsidiary company under the title of "ACI Global Scientific Standards Limited" having an authorized capital of BDT 50 (Fifty) Crore and a paid up capital of BDT 3 (Three) Crore wherein Advanced Chemical Industries PLC shall hold 85% shares, subject to the approval of the concerned authorities.

29 Jul 2026

UCB: Q2 Financials

(Q2 Un-audited): Consolidated EPS was Tk. 0.15 for April-June 2026 as against Tk. 0.08 for April-June 2025; Consolidated EPS was Tk. 0.22 for January-June 2026 as against Tk. 0.12 for January -June 2025; Consolidated NOCFPS was Tk. (16.42) for January - June 2026 as against Tk. 13.33 for January - June 2025. Consolidated NAV per share was Tk. 25.84 as on June 30, 2026 and Tk. 25.74 as on June 30, 2025. (cont.)

29 Jul 2026

NRBBANK: Q2 Financials

(Q2 Un-audited): Consolidated EPS was Tk. 0.01 for April-June 2026 as against Tk. (1.29) for April-June 2025; Consolidated EPS was Tk. 0.13 for January-June 2026 as against Tk. (1.24) for January-June 2025; Consolidated NOCFPS was Tk. 17.80 for January-June 2026 as against Tk. 4.79 for January-June 2025. Consolidated NAV per share was Tk. 13.08 as on June 30, 2026 and Tk. 12.93 as on December 31, 2025.

29 Jul 2026

ICBIBANK: Q2 Financials

(Q2 Un-audited): EPS was Tk. (0.35) for April-June 2026 as against Tk. (0.28) for April-June 2025; EPS was Tk. (0.72) for January-June 2026 as against Tk. (0.42) for January-June 2025. NOCFPS was Tk. (0.39) for January-June 2026 as against Tk. 1.38 for January-June 2025. NAV per share was Tk. (22.72) as on June 30, 2026 and Tk. (21.21) as on June 30, 2025.

29 Jul 2026

PURABIGEN: Q2 Financials

(Q2 Un-audited): EPS was Tk. 0.41 for April-June 2026 as against Tk. 0.45 for April-June 2025; EPS was Tk. 0.84 for January-June 2026 as against Tk. 0.78 for January-June 2025. NOCFPS was Tk. 1.01 for January-June 2026 as against Tk. 0.70 for January-June 2025. NAV per share was Tk. 15.50 as on June 30, 2026 and Tk. 14.29 as on December 31, 2025.

29 Jul 2026

AFCAGRO: Inspection of the factory premises of AFC Agro Biotech Ltd.

A team of DSE visited the factory premises of AFC Agro Biotech Limited on July 09, 2026 and found the operation/production closed.

29 Jul 2026

ACTIVEFINE: Inspection of the factory premises of Active Fine Chemicals Limited

A team of DSE visited the factory premises of Active Fine Chemicals Limited on June 25, 2026 and found the operation/production closed.

29 Jul 2026
EXCH

DSE NEWS: Regarding Lodging Investor Complaints through CCAM

The Investors are requested to lodge their complaints against the TREC Holder Companies and the issuer of listed securities (if any) of DSE through Customer Complaint Address Module (CCAM) (link: https://www.cdbl.com.bd/complaints.sec.gov.bd/) for addressing their complaints virtually.

29 Jul 2026
EXCH

DSE NEWS: Awareness message

DSE NEWS: All Stock Dealers, Stock Brokers and Authorized Representatives are asked to strictly follow the code of conduct as enumerated in the Second Schedule to the Securities and Exchange Commission (Stock Dealer, Stock Broker and Authorized Representative) Rules, 2000.

29 Jul 2026
EXCH

DSE NEWS: Awareness Message for Investors

DSE does not publish market data through any social media pages. INVESTORS should not rely on any information from an unauthorized source such as Facebook, WhatsApp, Viber, Linkedin etc. (cont.)

29 Jul 2026

BSEC NEWS: Awareness Message for Investors

Investors are requested to consider the following facts at the time of making investment decision in the Capital Market: 1. Without acquiring proper knowledge, information and experience regarding different aspects and matters of Capital Market, one should not invest in the Capital Market. 2. The gain or loss, whichever comes from the investment, it belongs to you. So, well - thought of investment decision based on knowledge and fundamentals of the securities may be real assistance to you. (cont.)

29 Jul 2026
EXCH

DSE NEWS: Greetings Message

Honorable Investors, Good morning! Please make your investment decision based on Company fundamentals, technical analysis, price level and disclosed information. Avoid rumor-based speculations.

29 Jul 2026
EXCH

DSE NEWS: Daily Turnover of Main Board

Today's (29.07.2026) Total Trades: 311,860; Volume: 505,039,949 and Turnover: Tk. 13,425.17 million.

29 Jul 2026

SEMLLECMF: Regarding de-listing of units of the Fund

Dhaka Stock Exchange PLC. (DSE) has approved the de-listing of the units of SEML Lecture Equity Management Fund from the bourse. The effective date of de-listing of units of SEML Lecture Equity Management Fund will be July 30, 2026.

29 Jul 2026

DSE NEWS: Withdrawal of Authorized Representative

Withdrawal of Authorized Representative: AIBL Capital Market Services Ltd. (DSE TREC No. 234) has withdrawn one of its Authorized Representatives, Mr. Giasuddin Ahmed.

29 Jul 2026

DSENEWS: Withdrawal of Authorized Representative

Withdrawal of Authorized Representative: Ettihad Securities Ltd. (DSE TREC No. 110) has withdrawn one of its Authorized Representatives, Mr. Nurul Wahed Siddique.

29 Jul 2026

UCB2PBOND: Resumption after Record Date

Trading of UCB 2nd Perpetual Bond will resume on 30-Jul-2026.

29 Jul 2026

FASFIN: Suspension for Record Date

Trading of the shares of the company will remain suspended on record date i.e., 30-Jul-2026.

29 Jul 2026

BIFC: Suspension for Record Date

Trading of the shares of the company will remain suspended on record date i.e., 30-Jul-2026.

29 Jul 2026

UCB: Spot News

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle from 30.07.2026 to 03.08.2026 and trading of the shares will remain suspended on record date i.e., 04.08.2026 for determination of entitlement of Rights Issue.

Latest Price
Workspace
AI Desk
Profile